Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Liabilities and Shareholders Equity (2021 - 2025)

Doximity (DOCS) has disclosed Liabilities and Shareholders Equity for 5 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 1.29% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 billion, a 9.89% increase, with the full-year FY2025 number at $1.3 billion, up 17.13% from a year prior.
  • Liabilities and Shareholders Equity was $1.2 billion for Q4 2025 at Doximity, down from $1.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.3 billion in Q1 2025 to a low of $251.7 million in Q1 2021.
  • A 5-year average of $1.0 billion and a median of $1.1 billion in 2022 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 293.83% in 2022, then dropped 6.94% in 2024.
  • Doximity's Liabilities and Shareholders Equity stood at $932.2 million in 2021, then increased by 14.47% to $1.1 billion in 2022, then decreased by 6.23% to $1.0 billion in 2023, then increased by 17.14% to $1.2 billion in 2024, then fell by 1.29% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Liabilities and Shareholders Equity are $1.2 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.2 billion (Q2 2025).